Fluidigm Launches Assays and Primers to Reduce Cost of Multiplexed Analysis, Drive Instrument Sales

"We expect these consumable products to help enable growth of instrument sales in the near term, and in the medium term allow us to participate significantly in the assays and primers revenue stream," said a company official.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.